Description

2-[3-(1,3-Dimethyl-2,6-Dioxo-Purin-7-Yl)Propyl]Guanidine, Sulfuric Acid is a high-purity chemical intermediate of significant importance in advanced pharmaceutical synthesis. This compound matters for its role as a key building block in the development of nucleoside analogs and other active pharmaceutical ingredients (APIs). Pharmaceutical manufacturers and advanced research institutions need this material for the production of targeted therapeutics, where consistent quality and reliable supply are paramount.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of nucleoside analog drugs, including potential antiviral and anticancer agents.
• Active Pharmaceutical Ingredient (API) Synthesis: Serves as a key building block for constructing complex molecular frameworks in API manufacturing under GMP conditions.
• Biochemical Research: Used in life science research for studying purine metabolism, enzyme inhibition, and cellular signaling pathways.
• Contract Development and Manufacturing (CDMO): Supplied to CDMOs for custom synthesis projects requiring high-purity, specialized intermediates.
• Reference Standard: Suitable for use as an analytical reference standard in quality control laboratories for method development and validation.

Basic Information

Product Name	2-[3-(1,3-Dimethyl-2,6-Dioxo-Purin-7-Yl)Propyl]Guanidine, Sulfuric Acid
CAS No.	85460-93-1
Molecular Formula	C11H17N7O2 • H2SO4
Molecular Weight	375.38 g/mol (for the salt)
Synonyms	7-(3-Guanidinopropyl)-1,3-dimethylxanthine Sulfate; 1,3-Dimethyl-7-(3-guanidinopropyl)xanthine Sulfate; 2-[3-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)propyl]guanidine Sulfate; 7-(3-Guanidinopropyl)theophylline Sulfate; SQ 22536 Sulfate; Adenylate Cyclase Inhibitor SQ 22536 (Sulfate Salt); SQ-22536 Sulfate; Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our 2-[3-(1,3-Dimethyl-2,6-Dioxo-Purin-7-Yl)Propyl]Guanidine, Sulfuric Acid is manufactured and tested to meet the stringent requirements of pharmaceutical R&D and production. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via IR and NMR. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment to ensure full traceability and compliance with your quality protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0%; Any single impurity ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.